The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration

Cell

Volumn 99, Issue 5, 1999, Pages 511-520

  Streblow, Daniel N ^a   Soderberg Naucler, Cecilia ^a,d   Vieira, Jeffrey ^b   Smith, Patricia ^a   Wakabayashi, Eiko ^b   Ruchti, Franziska ^a   Mattison, Kirsten ^a   Altschuler, Yoram ^c   Nelson, Jay A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

HUMAN HERPESVIRUS 5;

EID: 0033601104     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81539-1     Document Type: Article

References (61)

1. Ahuja, S.K., and Murphy, M.P. (1993). Molecular piracy of mammalian interleukin-8-receptor type B by herpesvirus saimiri. J. Biol. Chem. 268, 20691-20694.
2. Ahuja, S.K., Gao, J.L., and Murphy, P.M. (1994). Chemokine receptors and molecular mimicry. Immunol. Today 15, 281-287.
3. Aral, H., and Charo, I.F. (1996). Differential regulation of G-protein-mediated signaling by chemokine receptors. J. Biol. Chem. 271, 21814-21819.
4. Arvanitakis, L, Raaka-Geras, E., Varma, A., Gershengorn, M.C., and Cesarman, E. (1997). Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385, 347-349.
5. Bacon, K.B., Premack, B.A., Gardner, P., and Schall, T.J. (1995). Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269, 1727-1730.
6. Bacon, K.B., Szabo, M.C., Yssel, H., Bolen, J.B., and Schall, T.J. (1996). RANTES induces tyrosine kinase activity of stably complexed P125FAK and ZAP-70 in human T-cells. J. Exp. Med. 784, 873-882.
7. Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E.G., Gutkind, J.S., Asch, A.S., Cersarman, E., Gerhengorn, M.C., and Mesri, E.A. (1998). G-protein-coupled receptor of Kaposi's sarcomaassociated herpesvirus is a viral oncogene and angiogenesis activator. Nature 397, 86-89.
8. Benditt, E., Barrett, T., and McDougall, J. (1983). Viruses in the etiology of atherosclerosis. Proc. Natl. Acad. Sci. USA 80, 6386-6389.
9. Billstrom, M.A., Johnson, G.L., Avdi, N.J., and Worthen, G.S. (1998). Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. J. Virol. 72, 5535-5544.
10. Bodaghi, B., Jones, T.R., Zipeto, D., Vita, C., Sun, L., Laurent, L., Arenzana-Seisdedos, F., vlrelizier, J.L, and Michelson, S. (1998). Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Med. 788, 855-866.
11. Bokoch, G.M. (1995). Chemoattractant signaling and leukocyte activation. Blood 86, 1649-1660.
12. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897.
13. Boshoff, C. (1998). Coupling herpesviruses to angiogenesis. Nature 397, 24-25.
14. Boshoff, C., Endo, Y., Collins, P.D., Takeuchi, Y., Reeves, J.D., Schweickart, V.L., Siani, M.A., Sasaki, T., Williams, T.J., Gray, P.W., Moore, P.S., Chang, Y., and Weiss, R.A. (1997). Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290-294.
15. Bruning, J.H., Persoons, M.C.J., Lemstrom, K.B., Stals, F.S., De Clereq, E., and Bruggeman, C.A. (1994). Enhancement of transplantation associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Transplant Int. 7, 365-370.
16. Burgstahler, R., Kempkes, B., Steube, K., and Lipp, M. (1995). Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2. Biochem. Biophys. Res. Commun. 275, 737-743.
17. Cary, L.A., Chang, J.F., and Guan, J.L. (1996). Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. 709, 1787-1794.
18. Chee, M.S., Bankier, A.T., Beck, S., Bohni, R., Brown, C.M., Cerny, R., Horsnell, T., Hutchison, C.A., III, Kouzarides, T., Martignetti, J.A., et al. (1990a). Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154, 125-169.
19. Chee, M.S., Satchwell, S.C., Preddie, E., Weston, K.M., and Barrell, B.G. (1990b). Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 344, 774-777.
20. Davis-Poynter, N.J., Lynch, D.M., Vally, H., Shellam, G.R., Rawlinson, W.D., Barrel, B.G., and Panel, H.E. (1997). Identification and characterization of a G protein-coupled receptor homolog endcoded by murine cytomegalovirus. J. Virol. 77, 1521-1529.
21. Fabricant, C., Fabricant, J., Minick, C., and Litrenta, M. (1983). Herpesvirus-induced atherosclerosis in chickens. Fed. Proc. 42, 2476-2479.
22. Gao, J.L., and Murphy, P. (1994). Human cytomegalovirus open reading US28 encodes a functional β chemokine receptor. J. Biol. Chem. 269, 28539-28542.
23. Gershengorn, M.C., Geras-Raaka, E., Varma, A., and dark-Lewis, I. (1999). Chemokines activate Kaposi's Sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J. Clin. Invest. 702, 1469-1472.
24. Gompels, U.A., Nicholas, J., Lawrence, G., Jones, M., Thomson, B.J., Martin, M.E., Efstathiou, S., Craxton, M., and Macaulay, H.A. (1995). The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209, 29-51.
25. Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
26. Gu, L, Okada, Y., Clinton, S.K., Gerard, C., Sukhova, G.K., Libby, P., and Rallins, B.J. (1998). Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275-281.
27. Guo, H.G., Browning, P., Nicholas, J., Hayward, G.S., Tschachler, E., Jiang, Y.W., Sadowska, M., Raffeld, M., Colombini, S., Gallo, R.C., and Reitz, M.S., Jr. (1997). Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's Sarcoma. Virology 228, 371-378.
28. Hendrix, M.G., Daemen, M., and Bruggeman, C.A. (1991). Cytomegalovirus nucleic acid distribution within the human vascular tree. Am. J. Pathol. 738, 563-567.
29. Hitt, M., Bett, A., Prevec, L, and Graham, F. (1994). Construction and propagation of human adenovirus vectors. In Cell Biology, J. Cells, ed. (New York: Academic Press), pp. 479-490.
30. Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., and Yamamoto, T. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544.
31. Inagami, T. (1999). Molecular biology and signaling of angiotensin receptors: an overview. J. Am. Soc. Nephrol. 10, S2-S7.
32. Jarvis, M.A., Wang, E., Meyers, H.L., Smith, P.A., Corless, C.L., Henderson, G.J., Vieira, J., Britt, W.J., and Nelson, J.A. (1999). Human cytomegalovirus infection of Caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol. 73, 4552-4560.
33. Kledal, T.N., Rosenkilde, M.M., Coulin, F., Simmons, G., Johnsen, A.H., Alouani, S., Power, C.A., Luttichau, H.R., Gerstoft, J., Clapham, P.R., et al. (1997). A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277, 1656-1659.
34. Kuhn, D.E., Beall, C.J., and Kolattukudy, P.E. (1995). The cytomegalovirus US28 protein binds multiple CC Chemokines with high affinity. Biochem. Biophys. Res. Commun. 277, 325-330.
35. Kundra, V., Anand-Apte, B., Feig, LA., and Zetter, B.R. (1995). The chemotactic response to PDGF-BB: evidence of a role for Ras. J. Cell Biol. 730, 725-731.
36. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Anal. Biochem. 227, 680.
37. Lalani, A.S., Masters, J., Graham, K., Liu, L., Lucas, A., and McFadden, G. (1999). Role of the myxoma virus soluble CC chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology 256, 233-245.
38. Lemstrom, K.B., Bruning, J.H., Bruggeman, C.A., Lautenschlager, I.T., and Hayry, P.J. (1993). Cytomegalovirus infection enhances smooth muscle cell proliferation and intimai thickening of rat aortic allografts. J. Clin. Invest. 92, 549-558.
39. Lu, M., and Shenk, T. (1996). Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transitiion from G1 to S. J. Virol. 70, 6097-6105.
40. Margulies, B.J., Browne, H., and Gibson, W. (1996). Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology 225, 111-125.
41. Massung, R.F., Jayarama, V., and Moyer, R.W. (1993). DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology 197, 511-528.
42. McDonald, K., Rector, T., Braunlin, E., Kubo, S., and Olivari, M. (1989). Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus. Am. J. Cardiol. 64, 359-360.
43. Mellado, M., Rodriguez-Frade, J.M., Aragay, A., del Real, G., Martin, A.M., Vila-Coro, A.J., Serrano, A., Mayor, F.J., and Martinez, A.C. (1998). The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J. Immunol. 161, 805-813.
44. Melnick, J.L, Petrie, B.L., Dreesman, G.R., Burek, J., McCollum, C.H., and DeBakey, M.E. (1983). Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 2, 644-647.
45. Melnick, J.L, Adam, E., and DeBakey, M.E. (1998). The link between CMV and atherosclerosis. Infect. Med. 15, 479-486.
46. Michelson, S., Dal Monte, P., Zipeto, D., Bodaghi, B., Laurent, L., Oberlin, E., Arenzana-Seisdedos, F., Virelizier, J., and Landini, M.P. (1997). Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J. Virol. 71, 6495-6500.
47. Nelken, N.A., Coughlin, S.R., Gordon, D., and Wilcox, J.N. (1991). Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88, 1121.
48. Neote, K., DiGregorio, D., Mak, J.Y., Horuk, R., and Schall, T.J. (1993). Molecular cloning, functional expression, and signaling characteristics of a CC chemokine receptor. Cell 72, 415-425.
49. Nicholas, J., Cameron, K.R., and Honess, R.W. (1992). Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature 355, 362-365.
50. Peterson, P.K., Balfour, H.H., Marker, S.C., Fryd, D.S., Howard, R.J., and Simmons, R.L. (1980). Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors, and inpact on renal transplantation. Medicine 59, 283-300.
51. Rodriguez-Frade, J.M., Vila-Corao, A.J., Martin, A., Nieto, M., Sanchez-Madrid, F., Proudfoot, A.E.I., Wells, T.N.C., Martinez, A.C., and Mellado, M. (1999). Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis. J. Cell Biol. 744, 755-765.
52. Rollins, B.J. (1997). Chemokines. Blood 90, 909-928.
53. Söderberg-Naucler, C., Fish, K., and Nelson, J.A. (1997). Reactivation of human cytomegalovirus in a novel dendritic cell phenotype from healthy donors. Cell 97, 119-126.
54. Speir, E., Modali, R., Huang, E.S., Leon, M.B., Shawl, F., Finkel, T., and Epstein, S.E. (1994). Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391-394.
55. Telford, E.A., Watson, M.S., Aird, H.C., Perry, J., and Davison, A.J. (1995). The DNA sequence of equine herpesvirus 2. J. Mol. Biol. 249, 520-528.
56. Terkeltaub, R., Boisvert, W.A., and Curtiss, L.K. (1998). Chemokines and atherosclerosis. Curr. Opin. Lipidol. 9, 397-405.
57. Tumilowicz, J.J., Gawlik, M.E., Powell, B.B., and Trentin, J.J. (1985). Replication of cytomelgalovirus in human arterial smooth muscle cells. J. Virol. 56, 839-845.
58. Vieira, J., Schall, T.J., Corey, L, and Geballe, A.P. (1998). Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescence protein gene. J. Virol. 72, 1-8.
59. Yla-Herttuala, S., Lipton, B.A., Rosenfeld, M.E., Sarkioja, T., Yoshimura, T., Leonard, E.J., Witztum, J.L, and Steinberg, D. (1991). Expression of monocyte chemoattractant protein 1 in macrophagerich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88, 5252.
60. Zhou, Y.F., Leon, M.B., Waclawiw, M.W., Popma, J.J., Yu, Z.X., Finkel, T., Epstein, S.E. (1996). Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 335, 624-630.
61. Zhou, Y.F., Yu, Z.X., Wanishsawad, C., Shou, M., and Epstein, S.E. (1999). The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF β-receptor. Biochem. Biophys. Res. Commun. 256, 608-613.